DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
-9.26%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$321M
AUM Growth
-$44.2M
(-12%)
Cap. Flow
-$7.59M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
50.52%
Holding
83
New
10
Increased
22
Reduced
13
Closed
8
Top Buys
| 1 |
Cytokinetics
CYTK
|
$4.32M |
| 2 |
TSVT
2seventy bio
TSVT
|
$3.73M |
| 3 |
Axogen
AXGN
|
$3.02M |
| 4 |
Merus
MRUS
|
$2.36M |
| 5 |
Tandem Diabetes Care
TNDM
|
$2.3M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$24.1M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$8.48M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$5.93M |
| 4 |
Lyra Therapeutics
LYRA
|
$1.48M |
| 5 |
Revolution Medicines
RVMD
|
$1.08M |
Sector Composition
| 1 | Healthcare | 82.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.05M | 1.26% |
92,887
-1,813
| -2% | -$79K |
|
27
Arcus Biosciences
RCUS
$1.23B
| $4M | 1.24% |
222,717
-3,000
| -1% | -$53.9K |
|
28
Viking Therapeutics
VKTX
$2.98B
| $3.54M | 1.1% |
319,655
+26,000
| +9% | +$288K |
|
29
Accuray
ARAY
$170M
| $3.32M | 1.03% |
1,222,358
| – | – |
|
30
Edgewise Therapeutics
EWTX
$1.54B
| $2.98M | 0.93% |
519,384
| – | – |
|
31
MediWound
MDWD
$182M
| $2.74M | 0.85% |
257,653
| – | – |
|
32
Century Therapeutics
IPSC
$41.4M
| $2.61M | 0.81% |
1,307,407
| – | – |
|
|
BCYC
33
Bicycle Therapeutics
BCYC
$483M
| $2.45M | 0.76% |
122,200
| – | – |
|
34
Amylyx Pharmaceuticals
AMLX
$887M
| $2.24M | 0.7% |
+122,547
| New | +$2.24M |
|
35
Procept Biorobotics
PRCT
$2.13B
| $2.21M | 0.69% |
67,300
+59,300
| +741% | +$1.95M |
|
36
Astria Therapeutics
ATXS
$395M
| $2.2M | 0.69% |
295,493
+167,840
| +131% | +$1.25M |
|
|
AUTL
37
Autolus Therapeutics
AUTL
$386M
| $2.16M | 0.67% |
928,253
-2,141
| -0.2% | -$4.99K |
|
38
Keros Therapeutics
KROS
$632M
| $2.1M | 0.65% |
65,961
+18,300
| +38% | +$583K |
|
39
Galapagos
GLPG
$2.1B
| $2.08M | 0.65% |
60,175
+7,500
| +14% | +$259K |
|
|
THRD
40
DELISTED
Third Harmonic Bio
THRD
| $1.92M | 0.6% |
+300,000
| New | +$1.92M |
|
|
BWAY
41
Brainsway
BWAY
$302M
| $1.75M | 0.54% |
432,181
-72,500
| -14% | -$293K |
|
|
RGLS
42
DELISTED
Regulus Therapeutics
RGLS
| $1.52M | 0.47% |
1,111,049
| – | – |
|
|
CMPS
43
Compass Pathways
CMPS
$489M
| $1.43M | 0.44% |
+193,000
| New | +$1.43M |
|
|
CERE
44
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.36M | 0.42% |
+62,200
| New | +$1.36M |
|
|
IMGN
45
DELISTED
Immunogen Inc
IMGN
| $1.32M | 0.41% |
+83,000
| New | +$1.32M |
|
46
Larimar Therapeutics
LRMR
$331M
| $1.29M | 0.4% |
327,373
-23,000
| -7% | -$90.9K |
|
|
SPRB
47
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $1.29M | 0.4% |
570,130
+258,130
| +83% | +$583K |
|
|
MREO
48
Mereo BioPharma
MREO
$275M
| $1.24M | 0.39% |
962,513
-46,500
| -5% | -$60K |
|
49
Gossamer Bio
GOSS
$571M
| $1.23M | 0.38% |
+1,476,052
| New | +$1.23M |
|
50
ProQR Therapeutics
PRQR
$252M
| $1.22M | 0.38% |
940,582
| – | – |
|